CEO Broughton Group Chris Allen is Chief Executive Officer and Co-Founder of Broughton. With more than 25 years of experience in analytical and regulatory science, he has worked across pharmaceuticals, medical devices, and nicotine products, including inhaled and solid dose formulations.
Chris has extensive expertise working with global regulatory authorities such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). Under his leadership, Broughton has supported Medicinal Marketing Authorisation Applications (MAA), EU Tobacco Products Directive (TPD) submissions, US Premarket Tobacco Product Applications (PMTA), and other international regulatory pathways.
Beschreibung_en
CEO Broughton Group Chris Allen is Chief Executive Officer and Co-Founder of Broughton. With more than 25 years of experience in analytical and regulatory science, he has worked across pharmaceuticals, medical devices, and nicotine products, including inhaled and solid dose formulations.
Chris has extensive expertise working with global regulatory authorities such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). Under his leadership, Broughton has supported Medicinal Marketing Authorisation Applications (MAA), EU Tobacco Products Directive (TPD) submissions, US Premarket Tobacco Product Applications (PMTA), and other international regulatory pathways.
